\nVaccinul \u00eempotriva COVID-19 Nuvaxovid, dezvoltat de Novavax, a primit aprobarea pentru a fi folosit \u00een UE. <\/p>\n
\nComisia European\u0103 a acordat luni o autoriza\u0163ie de introducere pe pia\u0163\u0103 condi\u0163ionat\u0103 (AIC) pentru vaccinul \u00eempotriva COVID-19 Nuvaxovid, dezvoltat de Novavax. Acesta este al cincilea vaccin \u00eempotriva COVID-19 autorizat \u00een UE.<\/p>\n
\nAutoriza\u0163ia se acord\u0103 \u00een urma unei recomand\u0103ri \u015ftiin\u0163ifice pozitive bazate pe o evaluare aprofundat\u0103 a siguran\u0163ei, eficacit\u0103\u0163ii \u015fi calit\u0103\u0163ii vaccinului de c\u0103tre Agen\u0163ia European\u0103 pentru Medicamente (EMA) \u015fi este aprobat\u0103 de statele membre.<\/p>\n
\nComisia European\u0103 a semnat contractul cu Novavax \u00een august 2021. \u00cen urma eliber\u0103rii de introducere pe pia\u0163\u0103 condi\u0163ionat\u0103, Novavax va fi \u00een m\u0103sur\u0103 s\u0103 livreze c\u0103tre UE p\u00e2n\u0103 la 100 de milioane de doze din vaccinul s\u0103u \u00eempotriva COVID-19 \u00eencep\u00e2nd cu primul trimestru al anului 2022.<\/p>\n
\nContractul permite statelor membre s\u0103 achizi\u0163ioneze \u00eenc\u0103 100 de milioane de doze \u00een cursul anilor 2022 \u015fi 2023. Sosirea primelor doze este a\u015fteptat\u0103 \u00een primele luni ale anului 2022, iar pentru primul trimestru statele membre au comandat aproximativ 27 de milioane de doze.<\/p>\n
\nAceast\u0103 cantitate se va ad\u0103uga cantit\u0103\u0163ii totale de 2,4 miliarde doze de vaccin produse de BioNTech-Pfizer, celor 460 de milioane de doze de vaccin produse de Moderna, celor 400 de milioane de doze produse de AstraZeneca, precum \u015fi celor 400 de milioane de doze produse de Jansen, anun\u0163\u0103 CE.<\/p>\n
\n <\/p>\n","protected":false},"excerpt":{"rendered":"
Vaccinul \u00eempotriva COVID-19 Nuvaxovid, dezvoltat de Novavax, a primit aprobarea pentru a fi folosit \u00een UE. Comisia European\u0103 a acordat luni o autoriza\u0163ie de introducere pe pia\u0163\u0103 condi\u0163ionat\u0103 (AIC) pentru vaccinul \u00eempotriva COVID-19 Nuvaxovid, dezvoltat de Novavax. Acesta este al cincilea vaccin \u00eempotriva COVID-19 autorizat \u00een UE. Autoriza\u0163ia se acord\u0103 \u00een urma unei recomand\u0103ri \u015ftiin\u0163ifice […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[9152,32766,50305,528,14930],"class_list":["post-199921","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-aprobare","tag-folosire","tag-novavax","tag-uniunea-europeana","tag-vaccin"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/199921","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=199921"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/199921\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=199921"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=199921"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=199921"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}